"Plasma cell gingivitis" encompasses multiple entities: a retrospective series of 37 cases.


Journal

European journal of dermatology : EJD
ISSN: 1952-4013
Titre abrégé: Eur J Dermatol
Pays: France
ID NLM: 9206420

Informations de publication

Date de publication:
01 Apr 2023
Historique:
medline: 12 7 2023
pubmed: 11 7 2023
entrez: 11 7 2023
Statut: ppublish

Résumé

Plasma cell gingivitis is defined as gingival inflammation comprised of plasma cell infiltrates. This diagnostic criterion is non-specific and underlying mechanisms remain unknown. We performed a multidisciplinary clinico-pathological review of cases previously identified as "gingivitis with plasma cell infiltrates", with assessment of putative contributing factors and critical appraisal of the final diagnosis. Cases previously identified as "gingivitis with plasma cell infiltrates" between 2000 and 2020 were included from archives from the GEMUB group, a French multidisciplinary network of physicians with expertise on oral mucosa. Among the 37 included cases, multidisciplinary clinico-pathological review allowed differential diagnosis in seven cases (oral lichen planus n=4, plasma cell granuloma n=1, plasmacytoma n=1, and mucous membrane pemphigoid n=1). The remaining cases were classified as "reactive plasma cell gingivitis" (induced by drugs, trauma/irritation or periodontal disease) (n=18) or "idiopathic plasma cell gingivitis" when no contributing factors were identified (n=12). Clinico-pathological characteristics did not differ significantly between "reactive" and "idiopathic" cases, preventing us from identifying specific features of "idiopathic" plasma cell gingivitis. "Plasma cell gingivitis" is a polymorphous, non-specific entity with various aetiologies, of which the diagnosis requires multidisciplinary anatomo-clinical correlation for exclusion of secondary causes of plasma cell infiltration. Although our study was limited by its retrospective design, most cases of "plasma cell gingivitis" appeared to be associated with an underlying cause. We propose a diagnostic algorithm to properly investigate such cases.

Sections du résumé

BACKGROUND BACKGROUND
Plasma cell gingivitis is defined as gingival inflammation comprised of plasma cell infiltrates. This diagnostic criterion is non-specific and underlying mechanisms remain unknown.
OBJECTIVES OBJECTIVE
We performed a multidisciplinary clinico-pathological review of cases previously identified as "gingivitis with plasma cell infiltrates", with assessment of putative contributing factors and critical appraisal of the final diagnosis.
MATERIALS & METHODS METHODS
Cases previously identified as "gingivitis with plasma cell infiltrates" between 2000 and 2020 were included from archives from the GEMUB group, a French multidisciplinary network of physicians with expertise on oral mucosa.
RESULTS RESULTS
Among the 37 included cases, multidisciplinary clinico-pathological review allowed differential diagnosis in seven cases (oral lichen planus n=4, plasma cell granuloma n=1, plasmacytoma n=1, and mucous membrane pemphigoid n=1). The remaining cases were classified as "reactive plasma cell gingivitis" (induced by drugs, trauma/irritation or periodontal disease) (n=18) or "idiopathic plasma cell gingivitis" when no contributing factors were identified (n=12). Clinico-pathological characteristics did not differ significantly between "reactive" and "idiopathic" cases, preventing us from identifying specific features of "idiopathic" plasma cell gingivitis.
CONCLUSION CONCLUSIONS
"Plasma cell gingivitis" is a polymorphous, non-specific entity with various aetiologies, of which the diagnosis requires multidisciplinary anatomo-clinical correlation for exclusion of secondary causes of plasma cell infiltration. Although our study was limited by its retrospective design, most cases of "plasma cell gingivitis" appeared to be associated with an underlying cause. We propose a diagnostic algorithm to properly investigate such cases.

Identifiants

pubmed: 37431113
pii: ejd.2023.4452
doi: 10.1684/ejd.2023.4452
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

109-120

Auteurs

Agathe Louisy (A)

Université François Rabelais, Tours, France, CHU Tours, Maxillo facial and stomatology Department, Tours, France.

Juliette Rochefort (J)

CHU Paris La Pitié Salpétrière, Oral medicine Department, Paris, France.

Françoise Plantier (F)

CHU Paris Cochin, Anatomopathology Department, Paris, France.

Thibault Kervarrec (T)

CHU Tours, Anatomopathology Department, Tours, France.

Pauline Quilhot (P)

CHU Paris La Pitié Salpétrière, Anatomopathology Department, Paris, France.

Scarlette Agbo Godeau (SA)

CHU Paris La Pitié Salpétrière, Maxillo facial and stomatology Department, Paris, France.

Emmanuelle Vigarios (E)

IUCT Oncopole, Dermatology Department, Toulouse, France.

Laurent Misery (L)

CHU Brest, Dermatology Department, Brest, France.

Sylvie Boisrame (S)

CHU Brest, Oral surgery Department, Brest, France.

Celine Bernardeschi (C)

CHU Paris La Pitié Salpétrière, Maxillo facial and stomatology Department, Paris, France.

Marie Helene Tessier (MH)

CHU Nantes, Dermatology Department, Nantes, France.

Marie Masson Regnault (MM)

CHU Poitiers, Dermatology Department, Poitiers, France.

Jean Noel Dauendorffer (JN)

CHU Paris Saint-Louis, Dermatology Department, Paris, France.

Christelle Le Roux-Villet (C)

CHU Bobigny Avicenne, Dermatology Department, Bobigny, France.

Alexandra Picard (A)

CHU Nice, Dermatology Department, Nice, France.

Margaux Garnier (M)

CHU Nice, Dermatology Department, Nice, France.

Sabine Mares De Metz (SM)

CHU Paris La Pitié Salpétrière, Maxillo facial and stomatology Department, Paris, France.

Corinne Husson (C)

CHU Paris Cochin, Dermatology Department, Paris, France.

Nathalie Beneton (N)

CH Le Mans, Dermatology Department, Le Mans, France.

Loic Vaillant (L)

Université François Rabelais, Tours, France, CHU Tours, Dermatology Department, Tours, France.

Jean-Christophe Fricain (JC)

CHU Bordeaux, Oral surgery Department, Bordeaux, France.

Mahtab Samimi (M)

Université François Rabelais, Tours, France, CHU Tours, Dermatology Department, Tours, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH